Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP. We have previously proposed that activated mesangial cells (MC) have a direct role in the initiation and propagation of inflammatory events within the glomerulus via the generation of the mesangioproliferative cytokine IL-6 and the chemokines IL-8 and MCP-1. The objective of this study was to investigate the role of cAMP in the regulation of IL-6 and IL-8 gene expression and peptide production in IL-I stimulated human MC. Agents known to elevate cAMP, including dibutyryl cAMP (db-cAMP), forskolin or isobutyl-methybcanthine (IBMX) were alone unable to induce IL-6 or IL-8 expression or production above media control levels, indicating activation of the cAMP pathway could not mimic IL-i signaling events. In the presence of IL-i, all three agents produced a marked potentiation of IL-6 mRNA expression and dose-dependent increase in IL-6 peptide production (twofold), but had little or no effect on IL-8 mRNA expression or peptide generation. In marked contrast cholera toxin (CT) caused a dose-dependent potentiation of both IL-I-induced IL-6 (." fourfold) and IL-8 peptide (" twofold) generation. The control agent, the purified binding subunit of cholera toxin (CT-B) which is devoid of ADPribosylating activity also enhanced IL-6 and IL-8 ( twofold) peptide generation indicating cAMP-independent mechanisms may be involved in the CT up-regulation of these cytokines. Treatment of MC with the cycloxygenase inhibitor indomethacin resulted in partial inhibition (37%) of IL-6 production but had no effect on IL-8 generation. Thus our data show that cAMP can potentiate IL-i induced IL-6 production, while having no effect on IL-8 induction, and PGE2 may operate via a positive feedback loop to up-regulate IL-i induced IL-6. Taken together, our results demonstrate that cAMP differentially regulates IL-6 and TL-8 production in IL-I-stimulated human MC.
glomerulus of the kidney. MC regulate a number of important functions including glomerular filtration rate (GFR) and matrix synthesis, as well as providing support for the capillary loops [1] . Increasing evidence from both in vitro and in vivo studies implicates mesangial cells, once considered a non-immune bystander cell, to participate in the initiation and maintenance of inflammatory events within the glomerulus, such as glomerulonephritis [2] . Mesangial cells can serve as both a source and target for numer-ous cytokines, eicosanoids and reactive oxygen intermediates [2, 3] . For example, we have demonstrated that human MC are a rich source of the neutrophil chemotactic peptide, IL-8, monocyte chemoattractant protein I (MCP-1) as well as the mesangioproliferative cytokine IL-6 when activated by the pro-inflammatory cytokines IL-i and TNF [4-61. The signaling mechanisms employed by IL-i to activate cells remain to be fully defined. IL-i induces a rapid change in the phosphorylation pattern of a large number of proteins chiefly on serine and threonine residues indicating activation of kinases or inhibition of phosphatases specific for these target residues [7] [8] [9] .
The kinases involved remain to be identified, but are thought to be novel since IL-i-induced phosphorylation events have been shown to be largely independent of cAMP-dependent protein kinase and protein kinase C activation [7, 101 . Furthermore, there is no consensus on whether IL-I generates cAMP or diacylglycerol, as some investigators have found changes in these second messengers and others have not [11, 12] . While the role of cAMP in IL-i signaling events remain controversial, addition of cAMP elevating agents to immunologically-stimulated cells can have important regulatory effects on cytokine production. For example, elevation of cAMP down-regulates IL-6 production by IL-i stimulated lung fibroblasts [13] , MCP-1 production by TNF stimulated mouse MC [14] and TNF production by endotoxin stimulated monocytes [15] .
Little is known about the regulatory effects of cAMP on cytokine production in mesangial cells. This study was designed, therefore, to examine the role of cAMP in the regulation of IL-6 and IL-8 gene expression and protein production in IL-I stimulated human MC. The effects of cAMP on IL-6 and IL-8 production were determined pharmacologically by utilizing agents which elevate cAMP, including dibutyryl cAMP (db-cAMP), forskolin and 3-isobutyl-1-methyl-xanthine (IBMX) or cholera toxin (CT), an agent which elevates cAMP via activation and ribosylation of the guannine nucleotide binding protein G (stimulatory protein) [16] . Our data demonstrates that cAMP differentially regulates IL-6 and IL-8 production in IL-i stimulated human MC. Membrane protein was resolved in a 12.5% SDS-polyacrylamide gel and autoradiographed. In lanes 3 to 5, the degree of G ribosylation that occurred on the initial exposure of intact cells to CT is inversely related to the amount of ribosylation observed on the autorad, which occurred during the second exposure of the cell membranes to CT in the presence of a [ 32P1-NAD label. The relevant part of the autorad is shown and is a representative experiment of 3 separate studies carried out on MC isolated from 2 donor kidneys.
British Bio-Technology (Oxford, UK). All components for the DIG nucleic acid detection system and the positively charged nylon membrane were purchased from Boehringer Mannheim Mesangial cell isolation and culture conditions Human mesangial cells (MC) were isolated from macroscopically normal portions of renal cortex, obtained from human kidneys immediately after surgical nephrectomy for renal carcinoma. Glomeruli were isolated by differential sieving and MC obtained by collagenase treatment as previously described [4] . Cultures were grown on either 1% gelatin coated tissue culture flasks or 24-multiwell tissue culture plates, in Waymouth medium MB 75 2/1 supplemented with 15% (vol/vol) heat-inactivated FCS, penicillin-streptomycin (10 U/mI and 10 pg/mI, respectively) and fungizone (0.5 xg/ml). MC identity was confirmed by the display of the characteristic hillock structures in culture [17] and by the use of a series of cell markers, as described previously [4] . MC in this study were used between passages 3 and 7.
Experimental protocol Confluent MC were either grown in 24-multiwell tissue culture plates (--5 X i0 cells/well) or in 25 cm2 flasks (--8 X io cells/flask). Twenty-four hours prior to the start of the experiment the cells were washed and cultured in serum-free medium to make quiescent. The agents under investigation (CT, CT-B, db-cAMP, forskolin, IBMX, indomethacin or vehicle) were added to duplicate wells or to flasks of quiescent MC for the times and doses specified in the Figure legends . A sub-maximal dose [4] of IL-la was added to the wells, which were incubated for a further 18 hours, before supernatants were collected, centrifuged to remove cellular debris and stored at -70°C until assayed for extracellular IL-8, IL-6 or PGE2. Similarly IL-la (3 ng/ml) was added to the flasks for five hours, before total cellular RNA was extracted for Northern analysis. Cell viability was routinely assessed at the end of the experiment by phase microscopy and by trypan blue exclusion.
Enzyme-linked immunoadsorbent assay (ELISA) for quantitation of IL-8 IL-8 in culture supernatants was quantitated using a doubleligand sandwich ELISA method as previously described [4] .
Immuno plates (Nunc) were coated with anti-human IL-8 mouse monoclonal antibody and detected with anti-human IL-8 goat polyclonal antibody conjugated to alkaline phosphatase. The substrate p-nitrophenyl phosphate was dissolved in 10% diethanolamine buffer, pH 9.8 to a final concentration of I mg/mI. Absorbance was read at 405 nm in an ELISA plate reader. The detection range of the assay was 200 to 2000 pg/mI.
ELISA for IL-6
Goat anti-human IL-6 antisera was affinity purified, and biotinylated according to the method described by Taktak et a! [18] . IL-6 in culture supernatants was detected using a double-ligand sandwich ELISA [18] . Detection was via the streptavidin-peroxidase system, using 0.2 mg/ml of the substrate o-phenylenediamine dihydrochioride (OPD) dissolved in 0.1 M citric acid-phosphate buffer, pH 5.0. Absorbance was read at 492 nm and the detection range was between 30 and 2000 pg/mI. Prostaglandin E2 (PGE2) assay PGE2 levels in culture supernatants were quantitated by radioimmunoassay using an iodinated analogue of PGE2, according to the manufacturers instructions (NEN Research products, Dupont). The detection range of the assay was 5 to 500 pg/ml.
Northern blot analysis
Total cellular RNA was extracted using 4 M guanidiniumthiocyanate buffer and isolated using phenol-chloroform (1:1 vol/vol) as previously described by Strieter et al [19] . After alcohol precipitation, RNA was quantitated by measuring absorbance at 260 nm and 10 pg per lane fractionated on a formaldehyde, 1% agarose gel. RNA was ethidium-bromide stained to confirm uniform loading. RNA was transferred overnight to positively hybridization solution (5 X SSC, 0.1% N-lauroylsarcosine, 0.02% SDS, 1% (wt/vol) Boehringer blocking reagent). Oligonucleotide probes were diluted to 10 ng/ml in hybridization solution. Membranes were washed and non-specific binding Sites blocked by incubating the membrane for 30 minutes in 1% (wt/vol) Boehringer blocking reagent. Bound probes were detected by antidigoxygenin antibody (1:10,000 dilution) coupled to alkaline phosphatase. Visualization is achieved using the chemiluminescent substrate lumigen PPD. Blots were exposed to X-ray film (Kodak Omat AR5) for approximately one to two hours at room temperature. Blots were quantitated by laser densitometry.
Preparation of cell membranes for ADP-ribosylation assay
Confluent, quiescent MC (3 X 106 cells/80 cm2 flasks) were treated with media alone or 100 nglml of cholera toxin for 30 minutes, two or four hours. Two flasks per time point were used. Cell membranes were prepared as described previously by O'Neill et al [20] . Briefly, cells were washed in phosphate-buffered saline sucrose. The membranes were homogenized by 50 strokes in a "tight" Dounce pestle, before being centrifuged for five minutes at 500 x g to remove nuclei and unbroken cells. A membrane enriched fraction was obtained following centrifugation of the supernatant at 25,000 X g for 30 minutes at 4°C. The resulting membrane pellets were resuspended in I ml of PBS + 1 mrvi PMSF and stored at -70°C until used in the ADP-ribosylation assay. Membrane protein was measured by the Coomassie brilliant blue dye binding method [21] , using IgG as standard.
ADP-nbosylation assay
Extracted membranes were exposed to CT or CT-B in the Peptide values were log10 transformed and data groups analyzed by two-way analysis of variance. Data which was significantly different at the P < 0.05 level was then compared using Dunnetts t-test for comparison of multiple groups to the control.
Results
Effect of cholera toxin on IL-I cx induced IL-6 and IL-8 peptide production by human mesangial cells Pretreatment of MC with CT (10 to 250 nglml) for five hours prior to the addition of IL-la resulted in a dose-dependent and significant (P < 0.05) increase in IL-6 ( Fig. 1A) and IL-8 ( Fig. 1B) production, compared to cells treated with IL-la alone. CT (250 nglml) enhanced IL-6 and IL-8 production by 297 56% and 106 24% (mean SCM), respectively, compared with IL-la control [IL-I control values = 5.1 1.5 ng/ml for IL-6 and 15 7.0 nglml for IL-8 production (mean SEM, N = 5)]. MC treated with CT alone (250 ng/ml) for the duration of the experiment showed no induction of IL-6 or JL-8 peptide above media control levels ( Fig.  1 A, B ).
To assess whether the mechanism of CT potentiation was through activation of G5 by ADP-ribosylation and subsequent elevation of cAMP, the effects of the purified binding subunit of cholera toxin (CT-B) on IL-la induced IL-6 and IL-8 peptide generation was investigated. CT-B can bind to the cell surface, but cannot modify G5 to activate the cAMP pathway due to the absence of A-subunit which is present in the whole toxin. Surpris-+ ingly, pretreatment with CT-B resulted in enhanced IL-6 ( Fig. 2A) and IL-8 ( Fig. 2B ) peptide production of 144 27% and 88 21% (mean SCM), respectively, compared to IL-i control. However, the potentiation of IL-Ia induced IL-6 production by CT-B was not dose-dependent over the dose range used. determined using a modification of the method previously described [20] . Briefly, 60 j.tg of membrane protein was incubated with 50 .tg/ml of pre-activated cholera toxin (incubated with 10 mM dithiothreitol for 20 mm at 30°C to release SI subunit) or cholera toxin B-subunit (CT-B), in 150 m potassium phosphate pH 7.5, 10 mM thymidine, 0.5 m ATP, 50 .LM GTP, 10 LM
[32P]NAD (50 to 100 pCi/mi), in a final volume of 100 pl. After incubating for 15 minutes at 30°C, the reaction was stopped by the addition of I ml of cold potassium phosphate buffer, the membranes collected by centrifugation, resuspended in 30 pl of sample buffer and proteins were separated by electrophoresis in a 12.5% SDS-polyaciylamide gel (20 x 16 cm) overnight at a constant current of 10 mA per gel [22] . The gel was Coomassie blue stained to determine equal loading, before being dried and exposed to X-ray film (Kodak X-Omat) for two days at -70°C with intensifying screens.
Ability of cholera toxin and the B-subunit to ADP-ribosylate mesangial cell membrane proteins ADP-ribosylation studies were carried out to confirm that CT was able to modify G proteins in MC within a five hour incubation with intact cells, and to check the purified CT-B preparation for contamination with A subunit. MC membranes treated with CT contained radiolabeled proteins of 42 kD and 52 kD (Fig. 3, lane 2) . These correspond to the molecular weights of two known forms of G protein [23] . To determine the extent of ADP-ribosylation, cells were treated for various times (0.5, 2, and 4 hr) with CT (100 ng/ml). Membranes were then prepared and a second exposure of 15 minutes to CT in the presence of [32P]-NAD was carried out. Any G5 ADP-ribosylated during the initial incubation of the cells would not have been available for ADPribosylation during the incubation of the isolated membranes with the toxin and [32P]-NAD. The intensity of the labeling by [32P] would therefore be inversely related to the amount ADP-ribosylated during the incubation of the cells with the toxin. Figure 3  (lanes 4, 5) shows that after two hours contact with CT all of the G5 protein was ADP-ribosylated. It was concluded that the conditions in which the CT enhanced IL-6 and IL-8 production (5 hr preincubation) would have resulted in a near-total ADPribosylation and activation of G. In contrast, treatment of MC membranes with B-subunit instead of CT failed to generate the 42 kD and 52 kD bands (Fig. 3, lane 1) , indicating no contamination of the CT-B preparation with A-subunit was observed. Ability of other cAMP-elevating agents to modulate IL-la induced IL-6 and IL-8 peptide production To clarify the role of cAMP in potentiating IL-ia induced IL-6 and IL-8, we went on to investigate the effect of agents that act via different mechanisms to elevate cAMP. Db-cAMP is a membrane permeable, hydrolysis resistant cAMP analogue [24] , while forskolin activates the catalytic subunit of the adenylyl cyclase enzyme to cause increases in intracellular cAMP levels [25] . IBMX is a non-specific phosphodiesterase inhibitor which prevents the respectively, compared to IL-ia alone. Similarly, a dose-dependent increase in IL-ia induced IL-6 was observed following a one hour IBMX pretreatment, 300 jiM of IBMX resulted in a 133 43% increase in IL-6 production ( Fig. 5A) . None of the cAMPelevating agents employed enhanced IL-la induced IL-6 production to the same extent as cholera toxin. In marked contrast, Db-cAMP, forskolin or IBMX in the presence of IL-la did not modify IL-8 production ( Figs. 4B and 5B ). None of these agents when added alone to the cells for the duration of the experiment caused any induction of IL-6 or IL-8 peptide above media control levels ( Figs. 4 and 5 ).
Effect of agents on IL-la induced IL-6 and IL-8 mRNA expression by mesangial cells
We next examined the effect of these agents on IL-6 and IL-8 gene expression. Figure 6A Effect of indomefhacin on IL-la induced IL-6 and IL-8 production Cytokine-activated human MC in culture are known to synthesize prostaglandins, and in particular PGE2 production is significantly increased above basal levels following IL-i stimulation 27].
MC respond to POE2 which upon receptor binding causes activation of G and elevation of intracellular cAMP 28]. To investigate whether POE2 plays a role in the IL-ia induction of IL-6, we incubated the cells with the cyclooxygenase inhibitor, indomethacin (0.1 to 10 jIM) for one hour prior to stimulation with IL-ia. Figure 8A shows that treatment with indomethacin resulted in almost complete inhibition of IL-la-induced PGE2 production. Greater than 97% of PGE2 production was inhibited at a concentration of 10 j.M indomethacin, while a 37 6% (mean SEM) reduction in IL-6 production was observed at the same concentration of indomethacin (Fig. 8B) . In contrast, indomethacm treatment had no inhibitory effect on IL-la-induced IL-8 generation (Fig. 8C) . The inhibitory effect of indomethacin on PGE2 and IL-6 production was not due to a toxic effect of the drug treatment, since cell viability as assessed by trypan blue exclusion was 100%. These results indicate that induction of IL-6 production in MC following IL-i stimulation may be potentiated by synthesis of PGE2, probably acting via stimulation of adenylyl cyclase.
Discussion
This study was undertaken to determine the role of cAMP in the regulation of IL-i induced expression of IL-6 and IL-8 in MC.
Our results show that agents that elevate cAMP (db-cAMP, forskolin and IBMX) significantly potentiated expression of IL-6 gene transcripts and peptide production in response to IL-in, while having little or no effect on IL-8 gene expression and peptide production. o In marked contrast, the bacterial toxin CT was unique in that it was found to cause significant enhancement of both IL-6 and IL-8 peptide generation in response to IL-in. CT produced a marked enhancement of IL-6 transcripts, but caused only a minor, if any, increase in IL-8 transcripts, indicating that enhanced IL-8 peptide levels may result from post-transcriptional effects of CT. Our data A '7 * enhanced IL-la-induced IL-6 mRNA levels, compared with cells treated with IL-la alone.
In comparison, Figure 7 demonstrates that pretreatment with IBMX (300 .tM) or CT-B (100 ng/ml) had no effect on IL-la induced IL-8 mRNA levels compared with the IL-la control, fold increase observed in IL-6 production following holotoxin pretreatment compared to CT-B pretreatment may be due to the presence of A-subunit, and consequently suggests some involvement of cAMP-dependent mechanisms in the CT up-regulation of IL-6. In comparison, CT-B and holotoxin (at 250 nglml) induced similar fold increases in IL-8 generation. The contrasting dose effects of CT-B on IL-6 and IL-8 generation favors differential regulation of these cytokines. CT-B is known to bind to a specific cell surface receptor, the ganglioside GM1. Furthermore, binding of CT-B to GM1 has been reported to modulate intracellular calcium levels and growth in several cell types [30, 31] . In addition, an ability of the CT-B/GM I pathway to modulate iL-2 expression via cAMP-independent mechanisms has been previously described [30, 321. Studies have also indicated that CT can interfere with signaling pathways other than the cAMP pathway, an ability which is dependent on the ADP-ribosylating activity of the toxin [331. Such action by CT is thought to account for expression of JE, the mouse monocyte chemokine in BALB/3T3 cells [34] . Therefore, an ability of CT to modulate a number of different signaling pathways may account for its potentiating effects on IL-i-induced IL-8 generation and explain the large increases seen in IL-6 generation, which could not be mimicked fully by the other cAMP agonists.
From the results of this study, certain insights into the IL-I signaling mechanisms for IL-6 and IL-8 can be drawn. In our system, the lack of induction of either IL-6 or IL-8 gene expression or production in the presence of cAMP-elevating agents alone indicates an inability of cAMP to mimic the actions of IL-i.
The potentiating effect of cAMP on IL-6 production by IL-i, however, does indicate that the IL-i signaling pathway for IL-6 and the cAMP pathway interact. The ability of agents that elevate cAMP to potentiate IL-6 gene transcripts, as well as peptide production indicates that this cross-talk between the pathways is occurring at the level of gene expression. Whether cAMP is working to increase IL-6 mRNA stability, or transcription itself remains to be established. However, reports demonstrating an ability of cAMP to cause induction of transcription factors that are involved in IL-6 gene expression [35] , as well as in IL-I signaling [36, 37] lends to speculation that the potentiating effect of cAMP may be occurring at the level of transcription factor induction.
Studies in human FS-4 fibroblasts describe IL-6 mRNA expression on stimulation with cAMP-elevating agents alone [38] . Furthermore, cAMP was found to activate IL-6 transcription by a reporter gene assay in HeLa cells [31 and the murine monocytic cell line PU5-1.8 [35] . This contrasts with our findings in human MC. The inability of cAMP-elevating agents alone to cause any induction of IL-6 mRNA or peptide could be linked to the fact our experiments were undertaken on quiescent MC, depleted of FCS for 24 hours before use. Serum itself is known to induce IL-6 expression [39] , and the presence of serum immediately prior to agonist stimulation can result in pronounced increases in cAMP accumulation [40] . However, other studies undertaken on cells which were not depleted of serum [131 or which were stimulated in the presence of low serum concentrations [41] also report an inability of cAMP-elevating agents to stimulate IL-6 expression.
This indicates that cell specific differences exist in IL-6 gene regulation, which alone cannot be explained by differing culture conditions.
The ability of cAMP to enhance IL-6 generation in the presence of cytokines has been previously reported in a human astrocytoma cell line [411 and rat IEC epithelial cells [42] . In contrast Zitnik, Zheng and Elias [13] have shown cAMP to significantly inhibit IL-io induced IL-6 mRNA and peptide in a human lung fibroblast cell line. Furthermore, cAMP-elevating agents have been shown to down-regulate endotoxin induced IL-6 in Kupifer cells [43] and to have no effect on IL-6 generation in endotoxinstimulated mononuclear cells [44] . The reasons for the variations in the ability of cAMP to modulate IL-6 production are not clear, and are likely to involve cell specific differences. In addition, these findings may reflect an ability of factors such as the timing of cAMP elevation in relation to agonist stimulation [45] , the dose of cAMP-elevating agent employed [46] , the agonist used [47] and the activation state of the cell [48] to affect the type of regulation observed. Preliminary studies in our laboratory have shown that addition of db-cAMP simultaneously with IL-i, or five hours after IL-i stimulation (data not shown) resulted in a similar potentiation of IL-i induced IL-6 peptide, as described with a five hour pretreatment of the cells.
The inability of cAMP to modulate IL-i-stimulated IL-8 generation highlights differences between the regulation of IL-6 and IL-8 in human MC, and indicates that the pathway(s) used by IL-i to induce IL-8 is independent of the cAMP pathway. Reports in the literature describing an ability of cAMP to regulate IL-8 production in other cell types are limited [49, 50] , and have mainly involved the use of CT, which we suggest may exert its effects on IL-8 production by cAMP-independent means. However, cAMP has been demonstrated to suppress TNFc and interferon-y induced generation of the chemokine, monocyte-chemoattractant protein 1 (MCP-i) in mouse mesangial cells [14] . These data suggest that, although the chemokines IL-8 and MCP-I are structurally closely related, the signaling pathways engaged to induce the expression of these chemokines in mesangial cells are dependent on both the target cell type and the stimulus employed.
In vivo, prostaglandins are one of the main mediators known to exert modulatory effects on inflammatory events via activation of the cAMP pathway. Increased PGE2 synthesis in response to IL-la in cultured MC has been shown previously [27] . We have extended these findings by demonstrating that inhibition of IL-i induced PGE2 generation with indomethacin leads to a significant inhibition of IL-6 generation, but is without effect on the IL-8 production. This suggests that endogenous PGE2 production in IL-i stimulated MC operates via a positive feedback loop to up-regulate IL-6 generation, probably through the elevation of intracellular cAMP. This hypothesis is supported by the lack of effect of indomethacin on IL-i induced IL-8 generation, further supporting the data that IL-8 production is not modulated by cAMP-elevating agents such as PGE2.
Renewed interest in the use of cAMP-elevating compounds as a therapeutic approach to certain inflammatory disorders has arisen from studies demonstrating the ability of cAMP to downregulate TNFa production in endotoxin-stimulated mononuclear cells [15j and IL-6 production in IL-i-stimulated lung fibroblasts [13] . The results of the present study suggest such a strategy may not prove to be beneficial in the treatment of mesangioproliferative glomerulonephritis, in which dysregulated IL-6 production [51] and IL-S expression have been implicated [2] , due to the clear potentiating effects of cAMP on IL-i-stimulated IL-6 production and the lack of effect on IL-8 production in cultured human MC. However, further studies would need to be performed on proliferating cells, in the presence of other growth factors, to address the clinical relevance of these observations more fully and the net effect of cAMP on the cytokine network determined.
